SG Americas Securities
IDYA icon

SG Americas Securities’s IDEAYA Biosciences IDYA Stock Holding History

SG Americas Securities’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$892K Sell
23,928
-9,036
-27% -$277K ﹤0.01% 1957
2026
Q1 		$1.1M Buy
32,964
+3,468
+12% +$116K ﹤0.01% 1709
2025
Q4 		$1.02M Sell
29,496
-24,641
-46% -$786K ﹤0.01% 2004
2025
Q3 		$1.47M Buy
54,137
+34,020
+169% +$823K 0.01% 1153
2025
Q2 		$423K Buy
+20,117
New +$386K ﹤0.01% 1773
2025
Q1 		– Sell
-18,486
Closed -$475K – 3593
2024
Q4 		$475K Buy
18,486
+15,089
+444% +$427K ﹤0.01% 1383
2024
Q3 		$108K Sell
3,397
-8,378
-71% -$318K ﹤0.01% 3000
2024
Q2 		$413K Buy
11,775
+9,472
+411% +$375K ﹤0.01% 1774
2024
Q1 		$101K Buy
+2,303
New +$99K ﹤0.01% 2562
2023
Q4 		– Sell
-21,025
Closed -$567K – 3254
2023
Q3 		$567K Buy
+21,025
New +$533K 0.01% 1667
2023
Q2 		– Sell
-33,940
Closed -$466K – 2686
2023
Q1 		$466K Buy
33,940
+3,741
+12% +$62.3K 0.01% 1763
2022
Q4 		$549K Buy
30,199
+14,215
+89% +$239K 0.01% 1454
2022
Q3 		$238K Sell
15,984
-8,892
-36% -$115K ﹤0.01% 2170
2022
Q2 		$343K Buy
+24,876
New +$277K ﹤0.01% 2287
2022
Q1 		– Sell
-15,234
Closed -$360K – 3191
2021
Q4 		$360K Sell
15,234
-8,400
-36% -$195K ﹤0.01% 2348
2021
Q3 		$602K Buy
23,634
+10,545
+81% +$246K ﹤0.01% 2335
2021
Q2 		$275K Buy
13,089
+5,728
+78% +$118K ﹤0.01% 2205
2021
Q1 		$173K Buy
+7,361
New +$142K ﹤0.01% 2769

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SG Americas Securities's IDYA Position: Q2 2026 in Review

SG Americas Securities reduced its IDEAYA Biosciences (IDYA) stake by 27% in Q2 2026, selling an estimated $277K and leaving 23,928 shares worth $892K. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

SG Americas Securities first reported a position in IDYA in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.47M in Q3 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • SG Americas Securities held 23,928 shares of IDEAYA Biosciences worth $892K as of Q2 2026.
  • SG Americas Securities sold 9,036 IDEAYA Biosciences shares in Q2 2026, an estimated $277K.
  • IDEAYA Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1957 holding.
  • SG Americas Securities first reported a position in IDEAYA Biosciences in Q1 2021 and has held it in 18 quarters since.
  • SG Americas Securities's IDEAYA Biosciences position peaked at $1.47M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.